Beta-blockers in early-stage breast cancer: a systematic review and meta-analysis

BACKGROUND: Preclinical and retrospective studies suggest that beta-blockers are active against breast cancer. We carried out a systematic review and meta-analysis to assess the impact of beta-blockers on the outcomes of patients with early-stage breast cancer. METHODS: A systematic literature searc...

Descripción completa

Detalles Bibliográficos
Autores principales: Caparica, R., Bruzzone, M., Agostinetto, E., De Angelis, C., Fêde, Â., Ceppi, M., de Azambuja, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921512/
https://www.ncbi.nlm.nih.gov/pubmed/33639601
http://dx.doi.org/10.1016/j.esmoop.2021.100066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921512/
https://www.ncbi.nlm.nih.gov/pubmed/33639601
http://dx.doi.org/10.1016/j.esmoop.2021.100066

Ejemplares similares